» Articles » PMID: 38844671

A Randomized Controlled Trial of a Weight Loss Maintenance Program in Adults with Obesity: the WLM3P Study

Overview
Journal Eur J Clin Nutr
Date 2024 Jun 6
PMID 38844671
Authors
Affiliations
Soon will be listed here.
Abstract

Background/objectives: The escalating obesity epidemic necessitates effective, sustainable weight loss (WL) and maintenance strategies. This study aimed to evaluate the effectiveness of the Weight Loss Maintenance 3 Phases Program (WLM3P) in achieving a clinically significant long-term weight loss (WL) (≥5% initial WL at 18 months) in adults with obesity compared to a standard low-carbohydrate diet (LCD).

Subjects/methods: In this two-phase trial, 112 participants targeting initial WL (0-6 months) and subsequent maintenance (7-18 months) were randomly assigned to either WLM3P or LCD groups. Outcomes assessed included change in body weight (kg, %), improvements in body composition, and metabolic profile.

Results: Of 112 randomized participants, 69% (n = 77) completed the study. At 18 months, WL in the WLM3P group (n = 40) was 15.5 ± 8.3% compared to 9.6 ± 8.5% in the LCD group (n = 37) (p < 0.001). The odds ratio of achieving WL ≥ 10% and ≥15% were significantly higher in the WLM3P group. Complete-case analysis revealed significantly greater improvements in BMI, body fat mass, visceral fat area, waist circumference, waist-to-hip ratio, HDL, and triglyceride/HDL ratio in WLM3P than in LCD. No serious adverse events were reported.

Conclusion: Both programs effectively promoted clinically relevant WL and its maintenance. However, the WLM3P program was more successful in helping participants achieve greater WL targets of ≥10% and ≥15%, along with other clinical benefits, after an 18-month intervention.

Trial Registration Number: NCT04192357.

References
1.
Fruhbeck G, Busetto L, Dicker D, Yumuk V, Goossens G, Hebebrand J . The ABCD of Obesity: An EASO Position Statement on a Diagnostic Term with Clinical and Scientific Implications. Obes Facts. 2019; 12(2):131-136. PMC: 6547280. DOI: 10.1159/000497124. View

2.
Durrer Schutz D, Busetto L, Dicker D, Farpour-Lambert N, Pryke R, Toplak H . European Practical and Patient-Centred Guidelines for Adult Obesity Management in Primary Care. Obes Facts. 2019; 12(1):40-66. PMC: 6465693. DOI: 10.1159/000496183. View

3.
Lv N, Azar K, Goldman Rosas L, Wulfovich S, Xiao L, Ma J . Behavioral lifestyle interventions for moderate and severe obesity: A systematic review. Prev Med. 2017; 100:180-193. PMC: 5503454. DOI: 10.1016/j.ypmed.2017.04.022. View

4.
Sun J, Tan Z, He C, Hu H, Zhai C, Qian G . Time-restricted eating with calorie restriction on weight loss and cardiometabolic risk: a systematic review and meta-analysis. Eur J Clin Nutr. 2023; 77(11):1014-1025. PMC: 10630127. DOI: 10.1038/s41430-023-01311-w. View

5.
Konstantinidi M, Koutelidakis A . Functional Foods and Bioactive Compounds: A Review of Its Possible Role on Weight Management and Obesity's Metabolic Consequences. Medicines (Basel). 2019; 6(3). PMC: 6789755. DOI: 10.3390/medicines6030094. View